Monika Davare, Associate Vice President for Basic Research at Oregon Health & Science University, shared on LinkedIn:
“November is Lung Cancer Awareness Month. My lab studies lung cancers driven by kinase alterations including ROS1, ALK, and NTRKs. Many of the patients whose tumors we study are young adults who never smoked. This work has taught me:
There is no typical lung cancer patient.
Many are young, otherwise healthy, and have never smoked.
Between 10 and 20 percent of people diagnosed with lung cancer never smoked, and about two thirds of them are women. Because lung cancer is still seen as a smoker’s disease, a persistent cough in a young never smoker is often attributed to asthma, allergies, or infection. Imaging comes late, and many patients are diagnosed at an advanced stage.

Lung cancer clinicians and patient advocates encourage anyone with a cough or breathing problem that does not resolve with treatment to talk with their doctor about whether chest imaging is appropriate, whatever their smoking history. For people diagnosed with non-small cell lung cancer, it is recommended that you ask about comprehensive biomarker testing, because many of these tumors carry alterations that approved targeted drugs can treat.
I am grateful to the foundations and patient advocacy groups that support people with lung cancer and fund research in this area, including GO2 for Lung Cancer, LUNGevity Foundation, Lung Cancer Research Foundation, Susan Wojcicki Foundation, The ROS1ders, ALK Positive, EGFR Resisters, NTRKers, and more.”
You can also read:
